Synthetic Peptide
NAT11 Synthetic Peptide, PEP-0996, from Invitrogen.
N-terminal acetylation is one of the most common protein modifications in eukaryotes, occurring on approximately 57% and 84% on yeast and human proteins respectively. There are several N-terminal acetylating enzyme complexes (NatA - NatE). Unlike the other complexes, NatD is composed of a single protein, NAT11, and has recently been described to acetylate the Serine N-termini of histones H2A and H4 in yeast. The role these modifications play is unknown; yeast that do not express NAT11 grow at normal rates and have no observable phenotypes. The role of the human homolog is likewise unknown.
| Marque | Invitrogen |
|---|---|
| Réf. B-LABO | BL-RE-176901 |
| Réf. fabricant | 15379250 |
| Gene ID (Entrez) | 79829 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | Q86UY6 |
| Nom usuel | Human NAT11 |
| Concentration | 200 μg/mL |
| Contenu et stockage | -20°C |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | NAA40 |
| Lyophilisé | No |
| Conservateur | 0.02% sodium azide |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Tampon de stockage | PBS |
